Innovation starts from the heart. At Edwards, we put patients first. We invest a significant proportion of our revenue towards research and development to drive and develop groundbreaking medical innovations for structural heart disease. As part of our R&D Engineering team, you will work closely with our Quality and Manufacturing teams to develop the latest tools and technologies to address significant, unmet clinical needs that impact patients’ lives around the world.
Edwards Lifesciences is looking for a System Integration Engineer to join our Innovation Center in Caesarea, Israel. In this role, you will lead the integration of sensors (ECG, Bioimpedance) into a heart valve system (delivery and implant). The role includes managing the tasks of 2-3 team members and 1-2 sub-contractors, leading the technical aspects of the mechanical, software, hardware and algorithm development, coordinating tasks to achieve R&D milestones, present project plans, value propositions and demonstrate feasibility to leadership while driving alignment with cross functional teams.
How you’ll make an impact:
Manage a project with a small team of engineers (3-5 people, no direct reports)
Deliver the R&D plan with needed adjustments
Lead design activities including brainstorming, conceptual design, feasibility testing and VoC.
Collaborate with cross functional teams (marketing, US based R&D).
Develop testing models to prove design theories and validate them.
Lead proof of concept development work including animal trials, in-vitro testing and supporting analyses.
Manage subcontractors in the fields of SW, HW and algorithm development.
What you'll need (Required):
B.Sc. in biomedical/electrical engineering.
At least 5 years of experience in R&D.
Analytical thinking and good planning abilities.
Project management or system level engineering experience.
Good understanding of SW/HW.
Proficiency in Python and MATLAB, and familiarity with Agile project management tools such as Jira.
About TMTT Business Unit:
Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pursuing an innovative portfolio of technologies to address a patient’s unmet clinical needs. It’s our driving force to help patients live longer and healthier lives. Join us and be part of our inspiring journey.